Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Prognostic indicators for long-term disability in multiple sclerosis patients.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
UCSF Neuroimmunology Research Seminar
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Proteomic analysis of the anti-inflammatory action of minocycline.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Structural mechanism for statin inhibition of HMG-CoA reductase.
Drug-induced thrombocytopenia secondary to natalizumab treatment.

Pages